Recognition of a dopamine replacement therapy dependence syndrome in Parkinson's disease: a pilot study

被引:43
作者
Bearn, J
Evans, A
Kelleher, M
Turner, K
Lees, A
机构
[1] Inst Psychiat, Natl Addict Ctr, London SE5 8AF, England
[2] UCL, Windeyer Med Inst, Reta Lila Weston Inst Neurolog Studies, London W1P 6DB, England
[3] Windeyer Med Inst, Reta Lila Inst Neurolog Studies, UCL 46, London W1P 6DB, England
关键词
Parkinson's disease; levodopa; drug dependence; cocaine;
D O I
10.1016/j.drugalcdep.2004.06.005
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Patients with Parkinson's disease may use Dopamine Replacement Therapy (DRT) in excess of therapeutic need. We investigate whether a group of 10 patients with Parkinson's disease, provisionally diagnosed with "Hedonistic Homeostatic Dysregulation" because of their excessive use of DRT, met established operational psychiatric criteria for substance dependence, compared with 10 patients with Parkinson's disease compliant with prescribed DRT. Using a semi-structured questionnaire designed to distinguish between adaptive therapeutic dependence on DRT and a maladaptive pathological pattern of DRT use, in conjunction with the SCID-1, we found that seven of the patients deemed by their treating physicians to be misusing DRT fulfilled operational criteria for maladaptive dependence in contrast to none of the compliant group. The majority experienced dysphoric "withdrawal" symptoms in the "off" state and increased their dose of DRT in an effort to control their mood. They also continued to use high doses of DRT despite disabling dyskinesias and social difficulties. This study provides preliminary evidence that some patients with Parkinson's disease may become maladaptively dependent on DRT. This finding has both clinical relevance for the treatment of PD and further implicates dopaminergic pathways in the genesis of substance dependence. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:305 / 310
页数:6
相关论文
共 23 条
[1]  
[Anonymous], 2000, DIAGN STAT MAN MENT
[2]   Smoking, alcohol, and coffee consumption preceding Parkinson's disease - A case-control study [J].
Benedetti, MD ;
Bower, JH ;
Maraganore, DM ;
McDonnell, SK ;
Peterson, BJ ;
Ahlskog, JE ;
Schaid, DJ ;
Rocca, WA .
NEUROLOGY, 2000, 55 (09) :1350-1358
[3]   MOVEMENT-DISORDERS [J].
CARDOSO, F ;
JANKOVIC, J .
NEUROLOGIC CLINICS, 1993, 11 (03) :625-638
[4]   Stigmatisation of people with mental illnesses [J].
Crisp, AH ;
Gelder, MG ;
Rix, S ;
Meltzer, HI ;
Rowlands, OJ .
BRITISH JOURNAL OF PSYCHIATRY, 2000, 177 :4-7
[5]   THE CONTRIBUTION OF AMPHETAMINE METABOLITES OF (-)-DEPRENYL TO ITS ANTIPARKINSONIAN PROPERTIES [J].
ELSWORTH, JD ;
SANDLER, M ;
LEES, AJ ;
WARD, C ;
STERN, GM .
JOURNAL OF NEURAL TRANSMISSION, 1982, 54 (1-2) :105-110
[6]  
FIRST MB, 1997, STRUCTURED CLIN ITNE
[7]   MIDBRAIN DOPAMINERGIC CELL LOSS IN PARKINSONS-DISEASE - COMPUTER VISUALIZATION [J].
GERMAN, DC ;
MANAYE, K ;
SMITH, WK ;
WOODWARD, DJ ;
SAPER, CB .
ANNALS OF NEUROLOGY, 1989, 26 (04) :507-514
[8]   Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies [J].
Giovannoni, G ;
O'Sullivan, JD ;
Turner, K ;
Manson, AJ ;
Lees, AJL .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2000, 68 (04) :423-428
[9]  
Harris D, 2000, AM J ADDICTION, V9, P28
[10]   Drug abuse: Hedonic homeostatic dysregulation [J].
Koob, GF ;
LeMoal, M .
SCIENCE, 1997, 278 (5335) :52-58